Testicular Cancer is when malignant cancer cells develop in one or both of the testicles in the germ cells. Testicular cancer is the most common cancer in men between the ages of 20-35 years old and is most commonly found in Caucasian men. Risk for developing testicular cancer are having an undescended testicle, family history, and abnormal development of the testicles. There are two main types of testicular cancers: seminomas and nonseminomas. Nonseminomas grow more rapidly and are less sensitive to radiation compared to seminomas. Testicular cancer can spread throughout the body through the tissues, the lymph system, and the blood. Testicular cancer stage indicates how large the cancer is, if it has spread to tissues near the testicle (T), whether or not it has spread to the lymph nodes (N), measures if it has metastasized (M), and monitors the level of tumor marker proteins in the serum or blood (S). These guidelines are based on the American Joint Committee on Cancer (AJCC). Once T, N, M, and S are scored, they are combined to indicate the stage of that case of testicular cancer.
Testicular Cancer Stage Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Testicular Cancer Stage below!
For more information on how to use Laverne, please read the How to Guide.
We have 823 products for the study of Testicular Cancer Stage that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.